| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10060340 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
| TVIS10062373 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
| TVIS10060326 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
| TVIS10060442 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ALB |
|---|---|
| DrugBank ID | DB11638 |
| Drug Name | Artenimol |
| Target ID | BE0000530 |
| UniProt ID | P02768 |
| Regulation Type | ligand |
| PubMed IDs | 8347159; 23684544 |
| Citations | Yang YZ, Asawamahasakda W, Meshnick SR: Alkylation of human albumin by the antimalarial artemisinin. Biochem Pharmacol. 1993 Jul 20;46(2):336-9.@@Veerappan A, Eichhorn T, Zeino M, Efferth T, Schneider D: Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin. Phytomedicine. 2013 Aug 15;20(11):969-74. doi: 10.1016/j.phymed.2013.04.003. Epub 2013 May 16. |
| Groups | Approved; Experimental; Investigational |
| Direct Classification | |
| SMILES | [H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)[C@@]([H])(O)O[C@]3([H])O[C@]4(C)CC[C@]1([H])[C@]23OO4 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL25164 |
